![]() | Up a level |
Prevalsek, D.; Fritsch, S.; Hubmann, M.; Zoellner, A.-K.; Koehnke, T.; Buecklein, V. L.; Mumm, F.; Haebe, S.; Witkowski, L.; Ledderose, G.; Stemmler, H.-J.; Spiekermann, K.; Hiddemann, W.; Hausmann, A.; Tischer, J. (2016): Sequential therapy in the setting of HLA-haploidentical transplantation utilizing T-cell-replete grafts and post-transplantation high-dose cyclophosphamide in the treatment of relapsed and refractory acute myeloid leukemia and myelodysplastic syndrome. In: Bone Marrow Transplantation, Vol. 51: S29-S30
Prevalsek, D.; Fritsch, S.; Hubmann, M.; Zoellner, A.-K.; Köhnke, T.; Engel, N.; Bücklein, V. L.; Schulz, C.; Mumm, F.; Berking, S.; Ledderose, G.; Stemmler, H.-J.; Spiekermann, K.; Hiddemann, W.; Hausmann, A.; Tischer, J. (2016): Results of sequential therapy in the setting of unmanipulated HLA-haploidentical transplantation utilizing post-transplantation high-dose cyclophosphamide in the treatment of high-risk AML and MDS. In: Oncology Research and Treatment, Vol. 39: pp. 77-78